Author

Russ Paulsen

Observed name: Russell Paulsen

Institution: UsAgainstAlzheimer

Observed institution: UsAgainstAlzheimer

ORCID: 0009-0002-8723-6659

Observed ORCID: 0009-0002-8723-6659

OpenAlex ID: A5061048533

Expanding the use of brief cognitive assessments to detect suspected early‐stage cognitive impairment in primary care

2023 · Soeren Mattke, Donnie Batie, et al. · Alzheimer s & Dementia · 71

PDF

Primary prevention recommendations to reduce the risk of cognitive decline

2022 · Marwan N. Sabbagh, Adriana Perez, et al. · Alzheimer s & Dementia · 60

PDF

Assessing What Matters to People Affected by Alzheimer’s Disease: A Quantitative Analysis

2023 · Brett Hauber, Russ Paulsen, et al. · Neurology and Therapy · 24

PDF

Technical Review of Clinical Outcomes Assessments Across the Continuum of Alzheimer's Disease

2023 · Dana B. DiBenedetti, Heather Menne, et al. · Neurology and Therapy · 18

PDF

Caring for Dementia Caregivers: Understanding Caregiver Stress During the COVID-19 Pandemic

2023 · Lee Lancashire, Virginia Biggar, et al. · Gerontology and Geriatric Medicine · 13

PDF

Measuring time saved in Alzheimer's disease: What is a meaningful slowing of progression?

2025 · Krista Lanctot, Linus Jönsson, et al. · Alzheimer s & Dementia Translational Research & Clinical Interventions · 6

PDF

Evaluating Elements of the Care Partner Experience in Individuals Who Care for People with Alzheimer's Disease Across the Severity Spectrum

2023 · Leigh F. Callahan, Brian Samsell, et al. · Neurology and Therapy · 5

PDF

Measuring What Matters Most to People Living with Alzheimer’s Disease and Care Partners: What Matters Most Quantitative Research Development

2024 · Carla (DeMuro) Romano, Emily Bratlee‐Whitaker, et al. · Alzheimer s & Dementia · 3

PDF

How do we put meaning into meaningful benefit? Perspectives from the lived experience

2025 · Russ Paulsen, Carla (DeMuro) Romano, et al. · Alzheimer s & Dementia Translational Research & Clinical Interventions · 2

PDF

Evaluation of what matters most in existing clinical outcomes assessments in Alzheimer's disease

2020 · Ann Hartry, Heather Menne, et al. · Alzheimer s & Dementia · 2

PDF

The value of patient-focused drug development

2026 · Allison Martin, Russ Paulsen · Nature Medicine · 1

Priority Ranking: What Matters Most to People Living with Alzheimer's Disease and Care Partners

2025 · Carla Romano, Emily Bratlee‐Whitaker, et al. · Alzheimer s & Dementia · 1

PDF

The importance of care partner input in Alzheimer’s disease (AD) drug development

2020 · Tabassum Majid, Russ Paulsen, et al. · Alzheimer s & Dementia · 1

PDF

Quantifying what matters most to patients and care partners in Alzheimer's disease

2020 · Brett Hauber, Russ Paulsen, et al. · Alzheimer s & Dementia · 1

PDF

Priorities of people living with Alzheimer's and care partners: What Matters Most?

2026 · Carla (DeMuro) Romano, Emily Bratlee‐Whitaker, et al. · Alzheimer s & Dementia

PDF

P47 Quality of Life and Utility Values Across the Alzheimer’s Disease Spectrum: Results From the What Matters Most Survey

2025 · William L. Herring, Carla (DeMuro) Romano, et al. · Value in Health

A pilot study to assess the effect of integrating an automated speech‐based cognitive assessment into a brain health platform on PCP visits

2025 · Vivian Vasallo, Nicklas Linz, et al. · Alzheimer s & Dementia

PDF

Expectation and perspectives of patients and physicians on new treatment for early Alzheimer Disease: Results of a physician survey and patient focus group interview

2024 · Joanne Bell, H. Ricky Kurzman, et al. · Alzheimer s & Dementia

PDF

Measuring “What Matters Most™” to individuals living with Alzheimer’s disease and care partners: A conceptual model of Alzheimer’s Disease

2023 · Carla (DeMuro) Romano, Christina Slota, et al. · Alzheimer s & Dementia

PDF

Works count: 19

Citation count: 208

H-index: 6

I10-index: 5